Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Developmental Psychology|December 15, 2010
Beyond event segmentation: spatial- and social-cognitive processes in verb-to-action mappingMargaret Friend, Amy PaceJournal of Experimental Child Psychology|February 5, 2013
Event-related potentials to intact and disrupted actions in children and adultsAmy Pace, Leslie J Carver, Margaret FriendNeurology and Therapy|February 9, 2017
Number Needed to Treat in Multiple Sclerosis Clinical TrialsMacaulay Okwuokenye, Annie Zhang, Amy Pace, et al.Journal of Experimental Psychology. Learning, Memory, and Cognition|January 13, 2017
A goal bias in action: The boundaries adults perceive in events align with sites of actor intentDani Levine, Kathy Hirsh-Pasek, Amy Pace, et al.Trials|July 15, 2020
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trialKeisha Smith, Amy Pace, Stephan Ortiz, et al.Neurology|November 4, 2009
Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT studyAndrew R Pachner, John D Warth, Amy Pace, et al.Child Development|July 15, 2017
Playing With Ideas: Evaluating the Impact of the Ultimate Block Party, a Collective Experiential Intervention to Enrich Perceptions of PlayRachel Grob, Mark Schlesinger, Amy Pace, et al.Advances in Child Development and Behavior|April 20, 2023
Cascades in language acquisition: Re-thinking the linear model of developmentLaura X Guo, Amy Pace, Lillian R Masek, et al.Infant Behavior & Development|February 15, 2020
Keeping the end in mind: Preliminary brain and behavioral evidence for broad attention to endpoints in pre-linguistic infantsAmy Pace, Dani F Levine, Roberta Michnick Golinkoff, et al.Multiple Sclerosis and Related Disorders|April 21, 2015
Natalizumab reduces relapse clinical severity and improves relapse recovery in MSFred D Lublin, Gary Cutter, Gavin Giovannoni, et al.Pageof 4